P905: IXAZOMIB-THALIDOMIDE-DEXAMETHASONE INDUCTION FOLLOWED BY IXAZOMIB OR PLACEBO MAINTENANCE IN NON-TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS; LONG-TERM RESULTS OF HOVON-126/NMSG 21.13. (23rd June 2022)

• Record Type: Journal Article
• Authors: Groen, K.; Seefat, M. R.; van der Holt, B.; Schjesvold, F. H.; Stege, C. A.; Levin, M.-D.; Hansson, M.; Leys, R. B.; Regelink, J.; Waage, A.; Szatkowski, D.; Axelsson, P.; Do, T. H.; Svirskaite, A.; van der Spek, E.; Haukas, E.; Knut-Bojanowska, D.; Ypma, P. F.; Blimark, C.; Mellqvist, U.-H.; van de Donk, N. W.; Sonneveld, P.; Klostergaard, A.; Vangsted, A. J.; Abdilgaard, N.; Zweegman, S.
• Is Part Of: HemaSphere. Volume 6(2022)Supplement 3
• Page Start: 796
• Page End: 797
• Publication Date: 2022-06-23
• Subjects: Hematology -- Periodicals; 616.15005
• DOI: 10.1097/01.HS9.0000846492.51234.76
• Languages: English
• ISSNs: 2572-9241